These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17671476)

  • 21. Pay increases for nonfounder executives at private life sciences companies rebound.
    Rychlik B
    Nat Biotechnol; 2013 Mar; 31(3):259-61. PubMed ID: 23471072
    [No Abstract]   [Full Text] [Related]  

  • 22. Expanding the innovation pool.
    Nat Biotechnol; 2012 Oct; 30(10):897. PubMed ID: 23051787
    [No Abstract]   [Full Text] [Related]  

  • 23. Fertile grounds.
    Russo G
    Nature; 2009 Oct; 461(7268):1308-9. PubMed ID: 19998548
    [No Abstract]   [Full Text] [Related]  

  • 24. Antisoma-Roche deal--a new kind of buyout?
    Mitchell P
    Nat Biotechnol; 2003 Jan; 21(1):3. PubMed ID: 12511894
    [No Abstract]   [Full Text] [Related]  

  • 25. Paths to entrepreneurship in the life sciences.
    Mehta S
    Nat Biotechnol; 2004 Dec; 22(12):1609-12. PubMed ID: 15605429
    [No Abstract]   [Full Text] [Related]  

  • 26. Innovation drives success in Switzerland's biotech scene.
    Whyte B
    Drug Discov Today; 2005 Oct; 10(20):1342-5. PubMed ID: 16253869
    [No Abstract]   [Full Text] [Related]  

  • 27. Thanks for sharing.
    Dolgin E
    Nat Med; 2013 Dec; 19(12):1556-8. PubMed ID: 24309644
    [No Abstract]   [Full Text] [Related]  

  • 28. Life sciences: all jazzed up.
    Mascarelli A
    Nature; 2012 Jun; 486(7403):429-31. PubMed ID: 22730564
    [No Abstract]   [Full Text] [Related]  

  • 29. Among the best.
    Jayaraman KS
    Nature; 2005 Jul; 436(7050):492-5. PubMed ID: 16049476
    [No Abstract]   [Full Text] [Related]  

  • 30. Anthony Coyle.
    Coyle A
    Nat Biotechnol; 2011 Mar; 29(3):187. PubMed ID: 21390006
    [No Abstract]   [Full Text] [Related]  

  • 31. Wage power in the life sciences.
    Lawrence S
    Nat Biotechnol; 2008 Jan; 26(1):14. PubMed ID: 18183005
    [No Abstract]   [Full Text] [Related]  

  • 32. Genzyme and Isis strike megadeal.
    Mack GS
    Nat Biotechnol; 2008 Mar; 26(3):251-3. PubMed ID: 18327216
    [No Abstract]   [Full Text] [Related]  

  • 33. What mergers can do for you.
    Acharya A
    Nat Biotechnol; 2011 Jun; 29(6):477-9. PubMed ID: 21796820
    [No Abstract]   [Full Text] [Related]  

  • 34. SOZO--a Euro-Japanese biotechnology conference.
    Veryard C
    IDrugs; 2005 Jul; 8(7):560-2. PubMed ID: 15973563
    [No Abstract]   [Full Text] [Related]  

  • 35. On the biotech block.
    Ossola A
    Nature; 2017 Oct; 550(7676):S168-S171. PubMed ID: 29045361
    [No Abstract]   [Full Text] [Related]  

  • 36. The lengthening handshake.
    Osborne R
    Nat Biotechnol; 2010 Mar; 28(3):197-9. PubMed ID: 20212476
    [No Abstract]   [Full Text] [Related]  

  • 37. DPI delivers biotechnology superstore. Discovery Partners International.
    Glaser V
    Nat Biotechnol; 1998 Dec; 16(13):1302. PubMed ID: 9853596
    [No Abstract]   [Full Text] [Related]  

  • 38. Niche indications could drive higher valuations.
    Ransom J
    Nat Biotechnol; 2006 Dec; 24(12):1457. PubMed ID: 17160028
    [No Abstract]   [Full Text] [Related]  

  • 39. The three pillars of bioentrepreneurship.
    Schoemaker HJ; Schoemaker AF
    Nat Biotechnol; 1998 May; 16 Suppl():13-5. PubMed ID: 9591253
    [No Abstract]   [Full Text] [Related]  

  • 40. Genentech grapples with direct offer.
    Huggett B
    Nat Biotechnol; 2009 Mar; 27(3):212. PubMed ID: 19270652
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.